Multiplexed LC–ESI–MRM‐MS‐based Assay for Identification of Coronary Artery Disease Biomarkers in Human Plasma
暂无分享,去创建一个
B. McManus | G. Francis | M. Anwar | D. Dai | Janet Wilson-McManus | Derek Smith | C. Borchers | John S. Hill | Gabriela V Cohen Freue | J. Hill | Darlene L Y Dai | Janet E. Wilson‐McManus
[1] W. Kannel,et al. Natural history of angina pectoris in the Framingham study. Prognosis and survival. , 1972, The American journal of cardiology.
[2] R. Cooks,et al. Multiple reaction monitoring in mass spectrometry/mass spectrometry for direct analysis of complex mixtures , 1978 .
[3] J. Travis,et al. The reactive site of human alpha 2-antiplasmin. , 1987, The Journal of biological chemistry.
[4] W. Weintraub,et al. Elevation of C-reactive protein in "active" coronary artery disease. , 1990, The American journal of cardiology.
[5] J. Griffin,et al. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. , 1993, The Journal of biological chemistry.
[6] M. Wojtukiewicz,et al. von Willebrand factor antigen and fibronectin in essential hypertension. , 1995, Thrombosis research.
[7] J. Griffin,et al. C-terminal Residues 621–635 of Protein S Are Essential for Binding to Factor Va* , 1999, The Journal of Biological Chemistry.
[8] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[9] A. Siegbahn,et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.
[10] A. Maseri,et al. Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular Disease: Predictive Role of C-Reactive Protein , 2002, Circulation.
[11] A. Maseri,et al. Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular Disease , 2002 .
[12] E Vuori,et al. Simultaneous screening for 238 drugs in blood by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[14] W. Gross,et al. Distribution spectrum of paraoxonase activity in HDL fractions. , 2004, Clinical chemistry.
[15] Thomas Lengauer,et al. ROCR: visualizing classifier performance in R , 2005, Bioinform..
[16] Leigh Anderson,et al. Candidate‐based proteomics in the search for biomarkers of cardiovascular disease , 2005, The Journal of physiology.
[17] K. Hajjar,et al. Molecular mechanisms of fibrinolysis , 2005, British journal of haematology.
[18] P. Libby,et al. Pathophysiology of Coronary Artery Disease , 2005, Circulation.
[19] K. Walley,et al. Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort , 2006, Canadian Medical Association Journal.
[20] A. Spitzer,et al. Mass Spectrometry in Neonatal Medicine and Clinical Diagnostics—the Potential Use of Mass Spectrometry in Neonatal Brian Monitoring , 2006 .
[21] A. Spitzer,et al. Mass spectrometry in neonatal medicine and clinical diagnosis--the [corrected] potential use of mass spectrometry in neonatal brain [corrected] monitoring. , 2006, Clinics in perinatology.
[22] L. Lipsitt,et al. Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: Still valid after all these years , 2007, Psychoneuroendocrinology.
[23] G. Gamba,et al. Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease , 1985, Acta diabetologia latina.
[24] J. L. López,et al. A better understanding of molecular mechanisms underlying human disease , 2007, Proteomics. Clinical applications.
[25] A. Engler,et al. Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. , 2008, Cancer research.
[26] Zhihe Liu,et al. Apolipoprotein L1, a Novel Bcl-2 Homology Domain 3-only Lipid-binding Protein, Induces Autophagic Cell Death* , 2008, Journal of Biological Chemistry.
[27] T. Hackeng,et al. Regulation of coagulation by protein S , 2008, Current opinion in hematology.
[28] Christoph H Borchers,et al. Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma* , 2009, Molecular & Cellular Proteomics.
[29] Christopher P Cannon,et al. Acute coronary syndromes: diagnosis and management, part I. , 2009, Mayo Clinic proceedings.
[30] T. Grimsrud,et al. Stability of selected serum proteins after long-term storage in the Janus Serum Bank , 2009, Clinical chemistry and laboratory medicine.
[31] S. Yusuf,et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.
[32] R. Aebersold,et al. Increased Selectivity, Analytical Precision, and Throughput in Targeted Proteomics , 2010, Molecular & Cellular Proteomics.
[33] John S. Hill,et al. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. , 2010, Journal of the American College of Cardiology.
[34] Galit Shmueli,et al. To Explain or To Predict? , 2010, 1101.0891.
[35] N. Anthonisen,et al. Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. , 2011, European heart journal.
[36] John S. Hill,et al. Combined Polymorphisms in Oxidative Stress Genes Predict Coronary Artery Disease and Oxidative Stress in Coronary Angiography Patients , 2012, Annals of human genetics.
[37] Raymond T. Ng,et al. A computational pipeline for the development of multi-marker bio-signature panels and ensemble classifiers , 2012, BMC Bioinformatics.
[38] E. Jansen,et al. Long term stability of paraoxonase-1 and high-density lipoprotein in human serum , 2012, Lipids in Health and Disease.
[39] Juncong Yang,et al. MRM‐based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma , 2012, Proteomics.
[40] M. Garelnabi,et al. Antioxidant and Anti-Inflammatory Role of Paraoxonase 1: Implication in Arteriosclerosis Diseases , 2012, North American journal of medical sciences.
[41] Jirí Jarkovský,et al. [Inflammatory response and C -reactive protein value in patient with acute coronary syndrome]. , 2013, Vnitrni lekarstvi.
[42] D. Girelli,et al. Paraoxonases: ancient substrate hunters and their evolving role in ischemic heart disease. , 2013, Advances in clinical chemistry.
[43] Raymond T. Ng,et al. Computational Biomarker Pipeline from Discovery to Clinical Implementation: Plasma Proteomic Biomarkers for Cardiac Transplantation , 2013, PLoS Comput. Biol..
[44] T. van der Poll,et al. Endogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis). , 2013, American journal of respiratory and critical care medicine.
[45] T. Funahashi,et al. Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin / total adiponectin ratio. , 2013, Metabolism: clinical and experimental.
[46] J. Wen,et al. ITIH4: A New Potential Biomarker of “Toxin Syndrome” in Coronary Heart Disease Patient Identified with Proteomic Method , 2013, Evidence-based complementary and alternative medicine : eCAM.
[47] Y. Zhang,et al. Serum Lipids, Apolipoproteins, and Mortality among Coronary Artery Disease Patients , 2014, BioMed research international.
[48] C. Rotimi,et al. High sensitivity C-reactive protein (Hs-CRP) remains highly stable in long-term archived human serum. , 2014, Clinical biochemistry.
[49] F. Borràs,et al. Human scavenger protein AIM increases foam cell formation and CD36‐mediated oxLDL uptake , 2014, Journal of leukocyte biology.
[50] K. Sutton-Tyrrell,et al. Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls , 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[51] N. Bogavac-Stanojević,et al. Factor analysis of risk variables associated with iron status in patients with coronary artery disease. , 2014, Clinical biochemistry.
[52] W. März,et al. Hemoglobin, iron metabolism and angiographic coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study). , 2014, Atherosclerosis.
[53] Xi-Long Zheng,et al. Lipoprotein lipase: from gene to atherosclerosis. , 2014, Atherosclerosis.
[54] B. McManus,et al. Proteomic biomarkers of recovered heart function , 2014, European journal of heart failure.
[55] P. D. de Groot,et al. Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network* , 2014, The Journal of Biological Chemistry.
[56] Maya Petersen,et al. Computationally efficient confidence intervals for cross-validated area under the ROC curve estimates. , 2015, Electronic journal of statistics.
[57] K. Matthews,et al. Complement proteins and arterial calcification in middle aged women: Cross-sectional effect of cardiovascular fat. The SWAN Cardiovascular Fat Ancillary Study. , 2015, Atherosclerosis.
[58] P. Serruys,et al. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome , 2015, Thrombosis and Haemostasis.
[59] R. Simó,et al. Novel insights in SHBG regulation and clinical implications , 2015, Trends in Endocrinology & Metabolism.
[60] Mark D. Huffman,et al. AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .
[61] A. Gedikbaşı,et al. Serum paraoxonase 1 activity in patients with iron deficiency anemia , 2016, Archives of medical science : AMS.
[62] D. Siscovick,et al. Associations of cortisol/testosterone and cortisol/sex hormone-binding globulin ratios with atherosclerosis in middle-age women , 2016, Atherosclerosis.
[63] A. Sangamwar,et al. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192 , 2016, PloS one.
[64] S. Rivière,et al. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia. , 2016, Archivos de cardiologia de Mexico.
[65] Gareth Ambler,et al. Review and evaluation of penalised regression methods for risk prediction in low‐dimensional data with few events , 2015, Statistics in medicine.
[66] C. Tovilla-Zárate,et al. Effects of paraoxonase 1 gene polymorphisms on heart diseases , 2016, Medicine.
[67] E. Martínez-Quintana,et al. Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary event. , 2017, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.
[68] C. Minelli,et al. The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study—Brief Report , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[69] G. Watts,et al. Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia. , 2017, Journal of clinical lipidology.